Frexalimab

From WikiMD's Wellness Encyclopedia

Frexalimab is an experimental drug that is currently being studied for its potential use in the treatment of various autoimmune diseases. It is a monoclonal antibody that targets the interleukin-6 receptor (IL-6R), a protein that plays a key role in the immune response.

Mechanism of action[edit | edit source]

Frexalimab works by binding to the IL-6R, thereby blocking the interaction between IL-6 and its receptor. This prevents the activation of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway, which is involved in the production of inflammatory cytokines.

Clinical trials[edit | edit source]

Several clinical trials have been conducted to evaluate the safety and efficacy of frexalimab in patients with autoimmune diseases. These trials have shown promising results, with patients experiencing a reduction in disease activity and an improvement in quality of life.

Potential applications[edit | edit source]

Frexalimab is being investigated for its potential use in the treatment of a variety of autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, and Crohn's disease. It may also have potential applications in the treatment of other inflammatory conditions, such as psoriasis and asthma.

See also[edit | edit source]

Frexalimab Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD